Search

everythinglearnresearchcommunity

for

Search:↓

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

S100A3 protein is crucial for hair shaft formation in mice.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Pantothenic acid helps mink hair follicles grow by affecting certain cell signals.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Women with hair loss had lower IGF-1 levels.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The research identified key proteins and genes that may influence wool bending in goats.